Intermolecular (IMI) Reports In-Line Q2 EPS; Issues Light Q3 Outlook

August 5, 2016 6:35 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Intermolecular (NASDAQ: IMI) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.2 million.


Intermolecular sees Q3 2016 EPS of ($0.12)-($0.10), versus the consensus of ($0.03). Intermolecular sees Q3 2016 revenue of $9.5-10.0 million, versus the consensus of $14.2 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment